On September 8, 2020 Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, reported that Dr. Amit Kumar, Anixa’s Chief Executive Officer, will present at the virtual 2020 H.C. Wainwright Global Investment Conference being held September 14-16, 2020 (Press release, Anixa Biosciences, SEP 8, 2020, https://ir.anixa.com/news/detail/957/anixa-biosciences-to-present-at-the-2020-h-c-wainwright-22nd-annual-global-investment-conference [SID1234564720]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
During the presentation, Dr. Kumar will provide an overview of Anixa’s business and highlight recent corporate achievements, including its discovery of therapeutic candidates against Covid-19, as well as anticipated milestones in its breast cancer vaccine and CAR-T based ovarian cancer therapeutic programs.
Details of Anixa’s presentation are as follows:
Event:
2020 H.C. Wainwright 22nd Annual Global Investment
Conference
Date:
Wednesday, September 16, 2020
Time:
10:00 a.m. ET
Login Information: